drugset / Trial / NCT03011476

Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease

NCT03011476

Phase 4 Unknown 20 enrolled Kyung Hee University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cholinergic deficiency in the brain can be related to gait and balance problems in Parkinson disease (PD). Recent clinical trials suggested a beneficial role of acetylcholinesterase inhibitors (AchEI) on gait in PD. In this study, the investigators are planning to study the influence of AchEI on a brain network for gait and balance in PD. As gait problem is prominent in postural instability and gait disturbance (PIGD) subtype, this study will focus on the patients with PIGD phenotype.

Timeline

Start
2017-04-11
Primary completion
2018-10-30
Completion
2018-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 10 mg

Indications